Therapeutic Dose Low Molecular Weight Heparins (LMWH), fondaparinux and argatroban Anticoagulation Guideline

Ref/ID: P130211(02)a V3.1

Download

This guideline contains advice on safe prescribing administration and monitoring of Low molecular weight heparin, fondaparinux and argatroban.
Note: This guideline offers advice on the therapeutic dosing of LMWH and fondaparinux and does not address thromboprophylaxis – for prophylactic dosing guidance please see the separate Prevention of Hospital Acquired Thrombosis (HAT) policy document.

Categories:

  • Miscellaneous clinical: Nursing, Allied health professionals (AHP)
  • Pharmacy: Prescribing, Medicines, Pain, Chemotherapy
  • Surgery: Neurosurgery, Orthopaedics, Urology, Vascular

Published: 01/10/2019

Status: Passed review date of 30/11/2022

Author: Elizabeth.lamerton@nca.nhs.uk

Owners:

  • Diagnostics & Pharmacy

Applicable to:

  • Salford Care Organisation

Supporting Documents